Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19
Francis K. Yoshimoto
The Protein Journal (2020) Vol. 39, Iss. 3, pp. 198-216
Open Access | Times Cited: 549

Showing 1-25 of 549 citing articles:

COVID-19 Vaccine: A comprehensive status report
Simran Kaur, Vandana Gupta
Virus Research (2020) Vol. 288, pp. 198114-198114
Open Access | Times Cited: 850
Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19
Davey L. Jones, Marcos Quintela‐Baluja, David W. Graham, et al.
The Science of The Total Environment (2020) Vol. 749, pp. 141364-141364
Open Access | Times Cited: 375
From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses
Nikhil Kirtipal, Shiv Bharadwaj, Sang Gu Kang
Infection Genetics and Evolution (2020) Vol. 85, pp. 104502-104502
Open Access | Times Cited: 276
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns
Natalia Redondo, Sara Zaldívar‐López, Juan J. Garrido, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 268
The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2
Natacha S. Ogando, Jessika C. Zevenhoven-Dobbe, Yvonne van der Meer, et al.
Journal of Virology (2020) Vol. 94, Iss. 23
Open Access | Times Cited: 262
SARS-CoV-2: from its discovery to genome structure, transcription, and replication
Ayslan Castro Brant, Wei Tian, Vladimır Majerčiak, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 217
Natural history of COVID-19 and current knowledge on treatment therapeutic options
Wagner Gouvêa dos Santos
Biomedicine & Pharmacotherapy (2020) Vol. 129, pp. 110493-110493
Open Access | Times Cited: 212
Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA
Shuai Yuan, Lei Peng, Jonathan J. Park, et al.
Molecular Cell (2020) Vol. 80, Iss. 6, pp. 1055-1066.e6
Open Access | Times Cited: 185
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
Bingqing Xia, Xu-Rui Shen, Yang He, et al.
Cell Research (2021) Vol. 31, Iss. 8, pp. 847-860
Open Access | Times Cited: 152
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
Narayanappa Amruta, Wesley H. Chastain, Meshi Paz, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 58, pp. 1-15
Open Access | Times Cited: 117
Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor
Jin‐Gu Lee, Weiliang Huang, Hangnoh Lee, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 116
Analysis of the initial lot of the CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel
Justin S. Lee, Jason Goldstein, J Moon, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0260487-e0260487
Open Access | Times Cited: 115
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic
Priyanka Shah, Gabriela Canziani, Erik P. Carter, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 108
Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19
Canrong Wu, Wanchao Yin, Yi Jiang, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 12, pp. 3021-3033
Open Access | Times Cited: 101
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
Renee L. Hajnik, Jessica A. Plante, Yuejin Liang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 662
Open Access | Times Cited: 94
Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
Ahmed I. Abulsoud, Hussein M. El‐Husseiny, Ahmed A. El-Husseiny, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113977-113977
Open Access | Times Cited: 88
SARS-CoV-2 Accessory Protein Orf7b Induces Lung Injury via c-Myc Mediated Apoptosis and Ferroptosis
Rushikesh Deshpande, Wangyang Li, Tiao Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1157-1157
Open Access | Times Cited: 13
The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19
Gideon Schreiber
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 123
Association between HLA gene polymorphisms and mortality of COVID‐19: An in silico analysis
Yusuke Tomita, Tokunori Ikeda, Ryo Sato, et al.
Immunity Inflammation and Disease (2020) Vol. 8, Iss. 4, pp. 684-694
Open Access | Times Cited: 113
Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage
Sandra Amor, Laura Fernández Blanco, David Baker
Clinical & Experimental Immunology (2020) Vol. 202, Iss. 2, pp. 193-209
Open Access | Times Cited: 93
The 2020 race towards SARS-CoV-2 specific vaccines
Tomasz M. Karpiński, Marcin Ożarowski, Agnieszka Seremak‐Mrozikiewicz, et al.
Theranostics (2020) Vol. 11, Iss. 4, pp. 1690-1702
Open Access | Times Cited: 91
In silico analyses on the comparative sensing of SARS‐CoV‐2 mRNA by the intracellular TLRs of humans
Abhigyan Choudhury, Nabarun Chandra Das, Ritwik Patra, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 4, pp. 2476-2486
Closed Access | Times Cited: 90
The landscape of antibody binding in SARS-CoV-2 infection
Anna S. Heffron, Sean McIlwain, Maya F. Amjadi, et al.
PLoS Biology (2021) Vol. 19, Iss. 6, pp. e3001265-e3001265
Open Access | Times Cited: 79
Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples
Brendan Miller, Ana Silverstein, Melanie Flores, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 77
Structure of the SARS-CoV-2 Nsp1/5′-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence
Naveen Vankadari, Nandhini Nisha Jeyasankar, Wilma Jerom Lopes
The Journal of Physical Chemistry Letters (2020) Vol. 11, Iss. 22, pp. 9659-9668
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top